KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Minority Interest (2018 - 2021)

Historic Minority Interest for Guardant Health (GH) over the last 4 years, with Q3 2021 value amounting to $59.4 million.

  • Guardant Health's Minority Interest rose 531.91% to $59.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $59.4 million, marking a year-over-year increase of 531.91%. This contributed to the annual value of $57.1 million for FY2020, which is 1512.1% up from last year.
  • Guardant Health's Minority Interest amounted to $59.4 million in Q3 2021, which was up 531.91% from $59.4 million recorded in Q2 2021.
  • In the past 5 years, Guardant Health's Minority Interest registered a high of $59.4 million during Q1 2021, and its lowest value of $41.8 million during Q4 2018.
  • Over the past 4 years, Guardant Health's median Minority Interest value was $49.6 million (recorded in 2019), while the average stood at $50.8 million.
  • Per our database at Business Quant, Guardant Health's Minority Interest crashed by 215.05% in 2020 and then skyrocketed by 3054.95% in 2021.
  • Guardant Health's Minority Interest (Quarter) stood at $41.8 million in 2018, then grew by 18.66% to $49.6 million in 2019, then increased by 15.12% to $57.1 million in 2020, then increased by 4.03% to $59.4 million in 2021.
  • Its last three reported values are $59.4 million in Q3 2021, $59.4 million for Q2 2021, and $59.4 million during Q1 2021.